LY-4337713

N/A

Report date: 2026/05/08 14:14:42
NME

Base Information

Drug NameLY-4337713
Drug Alias NameLY4337713LY-4337713
ClassificationRadiation-emitting products > Radioactive therapeutic agent
Mechanisms of ActionFibroblast activation protein alpha modulators
TargetsProlyl endopeptidase FAP
Therapy Area/IndicationsOvarian NeoplasmsStomach NeoplasmsColorectal Neoplasms +[7
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesNetherlandsGermany +[5
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaIND
Originator CompaniesEli Lilly And Company
China Registration ClassN/A

Develop Information

Active CompaniesEli Lilly And Company
Inactive CompaniesN/A
Active IndicationsOvarian NeoplasmsStomach NeoplasmsColorectal Neoplasms +[7
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A